Improving Hypertension Control in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a autoimmune disease associated with an increased risk of developing coronary artery disease (CAD) and premature death,. Traditional CAD risk factors like hypertension (HTN) are both very common and poorly controlled among RA patients. Patients with RA face significant challenges in controlling HTN. The goal of this project is to identify barriers to HTN care in patients with RA to reduce CAD events.
Conditions studied
Hypertension, Rheumatoid Arthritis
About this study
Rheumatoid arthritis (RA) is a autoimmune disease associated with an increased risk of developing coronary artery disease (CAD) and premature death,. Traditional CAD risk factors like hypertension (HTN) are both very common and poorly controlled among RA patients. Patients with RA face significant challenges in controlling HTN. The goal of this project is to identify barriers to HTN care in patients with RA to reduce CAD events.
Interventions
- Behavioral: Blood pressure intervention arm — The intervention will focus on empowering patients to actively participate in their HTN care, facilitating patient-provider communication, and creating a cohesive care team to close the coordination loop for HTN management. This pilot intervention will help achieve these goals by providing participants with home blood pressure monitors and teaching, improving patient-provider communication regarding blood pressure and RA management, and initiating care coordination between rheumatology and primary care providers.
Primary outcomes
- Intervention feasibility as measured by participant accrual rates (6 months)
- Intervention feasibility as measured by participant retention (6 months)
- Intervention feasibility as measured by adherence to blood pressure monitoring (6 months)
- Intervention feasibility as measured by adherence to survey reporting (6 months)
- Intervention feasibility as measured by sample characteristics (6 months)
- Intervention feasibility as measured by use of resources (6 months)
- Intervention feasibility as measured by sustainability of data collection procedures (6 months)
- Intervention acceptability as measured by qualitative interviews (6 months)
Eligibility information
Study locations
- Duke Health System, Durham, North Carolina 27710 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.